SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2003
United Therapeutics Corporation
| Delaware | 000-26301 | 52-1984749 | ||
| (State or Other | (Commission | (I.R.S. Employer | ||
| Jurisdiction of | File Number) | Identification Number) | ||
| Incorporation) |
| 1110 Spring Street | ||||
| Silver Spring, MD | 20910 | |||
| (Address of Principal Executive Offices) | (Zip Code) |
| Registrant’s telephone number, including area code: | ||
| (301) 608-9292 | ||
Item 12. Earnings Announcements or Releases.
On November 6, 2003, United Therapeutics Corporation (the “Company”) issued a press release setting forth its earnings for the Company’s quarterly fiscal period ended September 30, 2003. A copy of this press release is attached hereto as Exhibit 99.1. The Company does not intend for Exhibit 99.1 to be incorporated by reference into filings under the Securities Act of 1933 or the Securities Exchange Act of 1934.
Item 7. Exhibits
(c) Exhibits
Exhibit No. Description of Exhibit
99.1 Press release dated November 6, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| UNITED THERAPEUTICS CORPORATION |
||||||||
| Dated: November 6, 2003 |
By: /s/ Paul A. Mahon
Name: Paul A. Mahon Title: General Counsel |
EXHIBIT INDEX
| Exhibit No. | Description of Exhibit | |||
| 99.1 | Press release dated November 6, 2003 |